Involvement of c-Fos in fenretinide-induced apoptosis in human ovarian carcinoma cells

Valentina Appierto, M. G. Villani, E. Cavadini, R. Lotan, C. Vinson, F. Formelli

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Fenretinide (HPR), a synthetic retinold that exhibits lower toxicity than other retinoids, has shown preventive and therapeutic activity against ovarian tumors. Although the growth inhibitory effects of HPR have been ascribed to its ability to induce apoptosis, little is known about the molecular mechanisms involved. Since the proto-oncogene c-Fos has been implicated in apoptosis induction, we analyzed its role in mediating HPR response in a human ovarian carcinoma cell line (A2780) sensitive to HPR apoptotic effect. In these cells, HPR treatment caused induction of c-Fos expression, whereas such an effect was not observed in cells made resistant to HPR-induced apoptosis (A2780/HPR). Moreover, in a panel of other human ovarian carcinoma cell lines, c-Fos inducibility and HPR sensitivity were closely associated. Ceramide, which is involved in HPR-induced apoptosis, was also involved in c-Fos induction because its upregulation by HPR was reduced by fumonisin B1, a ceramide synthase inhibitor. The causal relationship between c-Fos induction and apoptosis was established by the finding of an increased apoptotic rate in cells overexpressing c-Fos. Similarly to that observed for c-Fos expression, HPR treatment increased c-Jun expression in HPR-sensitive but not in HPR-resistant cells, suggesting the involvement of the transcription factor activating protein 1 (AP-1) in HPR-induced apoptosis. In gene reporter experiments, HPR stimulated AP-1 transcriptional activity and potentiated the AP-1 activity induced by 12-tetradecanoylphorbol 13-acetate. Furthermore, inhibition of AP-1 DNA binding, by transfecting A2780 cells with a dominant-negative Fos gene, caused decreased sensitivity to HPR apoptotic effects. Overall, the results indicate that c-Fos plays a role in mediating HPR-induced growth inhibition and apoptosis in ovarian cancer cells and suggest that c-Fos regulates these processes as a member of the AP-1 transcription factor.

Original languageEnglish
Pages (from-to)270-279
Number of pages10
JournalCell Death and Differentiation
Volume11
Issue number3
DOIs
Publication statusPublished - Mar 2004

Fingerprint

Fenretinide
Apoptosis
Carcinoma
Activating Transcription Factor 1
fos Genes
Proteins
Cell Line
Ceramides
Retinoids
DNA-Binding Proteins
Tetradecanoylphorbol Acetate
Growth
Reporter Genes
Ovarian Neoplasms
Up-Regulation

Keywords

  • AP-1
  • Apoptosis
  • c-Fos
  • Fenretinide
  • Retinoids

ASJC Scopus subject areas

  • Cell Biology

Cite this

Appierto, V., Villani, M. G., Cavadini, E., Lotan, R., Vinson, C., & Formelli, F. (2004). Involvement of c-Fos in fenretinide-induced apoptosis in human ovarian carcinoma cells. Cell Death and Differentiation, 11(3), 270-279. https://doi.org/10.1038/sj.cdd.4401349

Involvement of c-Fos in fenretinide-induced apoptosis in human ovarian carcinoma cells. / Appierto, Valentina; Villani, M. G.; Cavadini, E.; Lotan, R.; Vinson, C.; Formelli, F.

In: Cell Death and Differentiation, Vol. 11, No. 3, 03.2004, p. 270-279.

Research output: Contribution to journalArticle

Appierto, V, Villani, MG, Cavadini, E, Lotan, R, Vinson, C & Formelli, F 2004, 'Involvement of c-Fos in fenretinide-induced apoptosis in human ovarian carcinoma cells', Cell Death and Differentiation, vol. 11, no. 3, pp. 270-279. https://doi.org/10.1038/sj.cdd.4401349
Appierto, Valentina ; Villani, M. G. ; Cavadini, E. ; Lotan, R. ; Vinson, C. ; Formelli, F. / Involvement of c-Fos in fenretinide-induced apoptosis in human ovarian carcinoma cells. In: Cell Death and Differentiation. 2004 ; Vol. 11, No. 3. pp. 270-279.
@article{2adc3e054dc84d709b66f5c4db69ec30,
title = "Involvement of c-Fos in fenretinide-induced apoptosis in human ovarian carcinoma cells",
abstract = "Fenretinide (HPR), a synthetic retinold that exhibits lower toxicity than other retinoids, has shown preventive and therapeutic activity against ovarian tumors. Although the growth inhibitory effects of HPR have been ascribed to its ability to induce apoptosis, little is known about the molecular mechanisms involved. Since the proto-oncogene c-Fos has been implicated in apoptosis induction, we analyzed its role in mediating HPR response in a human ovarian carcinoma cell line (A2780) sensitive to HPR apoptotic effect. In these cells, HPR treatment caused induction of c-Fos expression, whereas such an effect was not observed in cells made resistant to HPR-induced apoptosis (A2780/HPR). Moreover, in a panel of other human ovarian carcinoma cell lines, c-Fos inducibility and HPR sensitivity were closely associated. Ceramide, which is involved in HPR-induced apoptosis, was also involved in c-Fos induction because its upregulation by HPR was reduced by fumonisin B1, a ceramide synthase inhibitor. The causal relationship between c-Fos induction and apoptosis was established by the finding of an increased apoptotic rate in cells overexpressing c-Fos. Similarly to that observed for c-Fos expression, HPR treatment increased c-Jun expression in HPR-sensitive but not in HPR-resistant cells, suggesting the involvement of the transcription factor activating protein 1 (AP-1) in HPR-induced apoptosis. In gene reporter experiments, HPR stimulated AP-1 transcriptional activity and potentiated the AP-1 activity induced by 12-tetradecanoylphorbol 13-acetate. Furthermore, inhibition of AP-1 DNA binding, by transfecting A2780 cells with a dominant-negative Fos gene, caused decreased sensitivity to HPR apoptotic effects. Overall, the results indicate that c-Fos plays a role in mediating HPR-induced growth inhibition and apoptosis in ovarian cancer cells and suggest that c-Fos regulates these processes as a member of the AP-1 transcription factor.",
keywords = "AP-1, Apoptosis, c-Fos, Fenretinide, Retinoids",
author = "Valentina Appierto and Villani, {M. G.} and E. Cavadini and R. Lotan and C. Vinson and F. Formelli",
year = "2004",
month = "3",
doi = "10.1038/sj.cdd.4401349",
language = "English",
volume = "11",
pages = "270--279",
journal = "Cell Death and Differentiation",
issn = "1350-9047",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Involvement of c-Fos in fenretinide-induced apoptosis in human ovarian carcinoma cells

AU - Appierto, Valentina

AU - Villani, M. G.

AU - Cavadini, E.

AU - Lotan, R.

AU - Vinson, C.

AU - Formelli, F.

PY - 2004/3

Y1 - 2004/3

N2 - Fenretinide (HPR), a synthetic retinold that exhibits lower toxicity than other retinoids, has shown preventive and therapeutic activity against ovarian tumors. Although the growth inhibitory effects of HPR have been ascribed to its ability to induce apoptosis, little is known about the molecular mechanisms involved. Since the proto-oncogene c-Fos has been implicated in apoptosis induction, we analyzed its role in mediating HPR response in a human ovarian carcinoma cell line (A2780) sensitive to HPR apoptotic effect. In these cells, HPR treatment caused induction of c-Fos expression, whereas such an effect was not observed in cells made resistant to HPR-induced apoptosis (A2780/HPR). Moreover, in a panel of other human ovarian carcinoma cell lines, c-Fos inducibility and HPR sensitivity were closely associated. Ceramide, which is involved in HPR-induced apoptosis, was also involved in c-Fos induction because its upregulation by HPR was reduced by fumonisin B1, a ceramide synthase inhibitor. The causal relationship between c-Fos induction and apoptosis was established by the finding of an increased apoptotic rate in cells overexpressing c-Fos. Similarly to that observed for c-Fos expression, HPR treatment increased c-Jun expression in HPR-sensitive but not in HPR-resistant cells, suggesting the involvement of the transcription factor activating protein 1 (AP-1) in HPR-induced apoptosis. In gene reporter experiments, HPR stimulated AP-1 transcriptional activity and potentiated the AP-1 activity induced by 12-tetradecanoylphorbol 13-acetate. Furthermore, inhibition of AP-1 DNA binding, by transfecting A2780 cells with a dominant-negative Fos gene, caused decreased sensitivity to HPR apoptotic effects. Overall, the results indicate that c-Fos plays a role in mediating HPR-induced growth inhibition and apoptosis in ovarian cancer cells and suggest that c-Fos regulates these processes as a member of the AP-1 transcription factor.

AB - Fenretinide (HPR), a synthetic retinold that exhibits lower toxicity than other retinoids, has shown preventive and therapeutic activity against ovarian tumors. Although the growth inhibitory effects of HPR have been ascribed to its ability to induce apoptosis, little is known about the molecular mechanisms involved. Since the proto-oncogene c-Fos has been implicated in apoptosis induction, we analyzed its role in mediating HPR response in a human ovarian carcinoma cell line (A2780) sensitive to HPR apoptotic effect. In these cells, HPR treatment caused induction of c-Fos expression, whereas such an effect was not observed in cells made resistant to HPR-induced apoptosis (A2780/HPR). Moreover, in a panel of other human ovarian carcinoma cell lines, c-Fos inducibility and HPR sensitivity were closely associated. Ceramide, which is involved in HPR-induced apoptosis, was also involved in c-Fos induction because its upregulation by HPR was reduced by fumonisin B1, a ceramide synthase inhibitor. The causal relationship between c-Fos induction and apoptosis was established by the finding of an increased apoptotic rate in cells overexpressing c-Fos. Similarly to that observed for c-Fos expression, HPR treatment increased c-Jun expression in HPR-sensitive but not in HPR-resistant cells, suggesting the involvement of the transcription factor activating protein 1 (AP-1) in HPR-induced apoptosis. In gene reporter experiments, HPR stimulated AP-1 transcriptional activity and potentiated the AP-1 activity induced by 12-tetradecanoylphorbol 13-acetate. Furthermore, inhibition of AP-1 DNA binding, by transfecting A2780 cells with a dominant-negative Fos gene, caused decreased sensitivity to HPR apoptotic effects. Overall, the results indicate that c-Fos plays a role in mediating HPR-induced growth inhibition and apoptosis in ovarian cancer cells and suggest that c-Fos regulates these processes as a member of the AP-1 transcription factor.

KW - AP-1

KW - Apoptosis

KW - c-Fos

KW - Fenretinide

KW - Retinoids

UR - http://www.scopus.com/inward/record.url?scp=1542359577&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1542359577&partnerID=8YFLogxK

U2 - 10.1038/sj.cdd.4401349

DO - 10.1038/sj.cdd.4401349

M3 - Article

VL - 11

SP - 270

EP - 279

JO - Cell Death and Differentiation

JF - Cell Death and Differentiation

SN - 1350-9047

IS - 3

ER -